প্রকাশ: 05/02/2022
The director of
the US Centers for Disease Control and Prevention (CDC) signed off on
the US Food and Drug Administration's full approval of
Moderna Inc's Covid-19 vaccine in those aged 18 and over, the
agency said on Friday.
The vaccine has been in use under
the U.S Food and Drug Administration's emergency use authorization
since December 2020, and is now the second fully
approved vaccine for Covid-19 in the United States.
Earlier on Friday, a CDC panel voted unanimously
to recommend the vaccine's use, after the FDA
granted full approval of the shot on Monday.
While the FDA approves vaccines,
the CDC needs to sign off on how they will be implemented in the
United States. CDC Director Rochelle Walensky's green light is the
final formality of the approval process.
The vaccine will now be sold under the brand name
as Spikevax.
The Covid-19 vaccine from Pfizer Inc and
BioNTech SE received full approval for those aged 16 and over in
August.
Roughly 75 million people in the United States have
been fully-vaccinated with Moderna's shot.
প্রধান সম্পাদকঃ সৈয়দ বোরহান কবীর
ক্রিয়েটিভ মিডিয়া লিমিটেডের অঙ্গ প্রতিষ্ঠান
বার্তা এবং বাণিজ্যিক কার্যালয়ঃ ২/৩ , ব্লক - ডি , লালমাটিয়া , ঢাকা -১২০৭
নিবন্ধিত ঠিকানাঃ বাড়ি# ৪৩ (লেভেল-৫) , রোড#১৬ নতুন (পুরাতন ২৭) , ধানমন্ডি , ঢাকা- ১২০৯
ফোনঃ +৮৮-০২৯১২৩৬৭৭